CA2167287A1 - Enantioselective process for thiazole intermediates - Google Patents
Enantioselective process for thiazole intermediatesInfo
- Publication number
- CA2167287A1 CA2167287A1 CA002167287A CA2167287A CA2167287A1 CA 2167287 A1 CA2167287 A1 CA 2167287A1 CA 002167287 A CA002167287 A CA 002167287A CA 2167287 A CA2167287 A CA 2167287A CA 2167287 A1 CA2167287 A1 CA 2167287A1
- Authority
- CA
- Canada
- Prior art keywords
- borane
- process according
- reaction inert
- formula
- reacting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims description 37
- 239000000543 intermediate Substances 0.000 title description 3
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 title description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 claims abstract description 38
- 150000002576 ketones Chemical class 0.000 claims abstract description 28
- 239000003054 catalyst Substances 0.000 claims abstract description 23
- 150000001875 compounds Chemical class 0.000 claims abstract description 21
- BDOLXPFAFMNDOK-UHFFFAOYSA-N oxazaborolidine Chemical compound B1CCON1 BDOLXPFAFMNDOK-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229910000085 borane Inorganic materials 0.000 claims abstract description 19
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 36
- 238000006243 chemical reaction Methods 0.000 claims description 35
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 26
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical group [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 claims description 20
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims description 14
- 239000012442 inert solvent Substances 0.000 claims description 14
- 239000011541 reaction mixture Substances 0.000 claims description 13
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- 125000003545 alkoxy group Chemical group 0.000 claims description 12
- 125000005843 halogen group Chemical group 0.000 claims description 11
- 238000011065 in-situ storage Methods 0.000 claims description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 125000000623 heterocyclic group Chemical group 0.000 claims description 9
- 239000012298 atmosphere Substances 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- GEJJWYZZKKKSEV-KGLIPLIRSA-N (1s,2r)-2-amino-1,2-diphenylethanol Chemical compound C1([C@H](O)[C@H](N)C=2C=CC=CC=2)=CC=CC=C1 GEJJWYZZKKKSEV-KGLIPLIRSA-N 0.000 claims description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 5
- DLNKOYKMWOXYQA-VXNVDRBHSA-N (+)-norephedrine Chemical compound C[C@@H](N)[C@@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-VXNVDRBHSA-N 0.000 claims 4
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 claims 4
- 125000003944 tolyl group Chemical group 0.000 claims 3
- GEJJWYZZKKKSEV-UHFFFAOYSA-N 2-amino-1,2-diphenylethanol Chemical compound C=1C=CC=CC=1C(N)C(O)C1=CC=CC=C1 GEJJWYZZKKKSEV-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 6
- 239000002243 precursor Substances 0.000 abstract description 3
- 235000013350 formula milk Nutrition 0.000 abstract 3
- 239000002904 solvent Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 150000002118 epoxides Chemical class 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- UJPKMTDFFUTLGM-UHFFFAOYSA-N 1-aminoethanol Chemical class CC(N)O UJPKMTDFFUTLGM-UHFFFAOYSA-N 0.000 description 5
- MOIPGXQKZSZOQX-UHFFFAOYSA-N carbonyl bromide Chemical compound BrC(Br)=O MOIPGXQKZSZOQX-UHFFFAOYSA-N 0.000 description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- -1 1,2-disubstituted amino-ethanol Chemical class 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- YFONKFDEZLYQDH-OPQQBVKSSA-N N-[(1R,2S)-2,6-dimethyindan-1-yl]-6-[(1R)-1-fluoroethyl]-1,3,5-triazine-2,4-diamine Chemical compound C[C@@H](F)C1=NC(N)=NC(N[C@H]2C3=CC(C)=CC=C3C[C@@H]2C)=N1 YFONKFDEZLYQDH-OPQQBVKSSA-N 0.000 description 2
- 241000282320 Panthera leo Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 150000004678 hydrides Chemical class 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 238000011946 reduction process Methods 0.000 description 2
- 229930195734 saturated hydrocarbon Natural products 0.000 description 2
- BSWWXRFVMJHFBN-UHFFFAOYSA-N 2,4,6-tribromophenol Chemical compound OC1=C(Br)C=C(Br)C=C1Br BSWWXRFVMJHFBN-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- BSFODEXXVBBYOC-UHFFFAOYSA-N 8-[4-(dimethylamino)butan-2-ylamino]quinolin-6-ol Chemical compound C1=CN=C2C(NC(CCN(C)C)C)=CC(O)=CC2=C1 BSFODEXXVBBYOC-UHFFFAOYSA-N 0.000 description 1
- 101150092509 Actn gene Proteins 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000270281 Coluber constrictor Species 0.000 description 1
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000015107 ale Nutrition 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- ZDQWVKDDJDIVAL-UHFFFAOYSA-N catecholborane Chemical compound C1=CC=C2O[B]OC2=C1 ZDQWVKDDJDIVAL-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000002451 electron ionisation mass spectrometry Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- OQZCSNDVOWYALR-UHFFFAOYSA-N flurochloridone Chemical compound FC(F)(F)C1=CC=CC(N2C(C(Cl)C(CCl)C2)=O)=C1 OQZCSNDVOWYALR-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- YWXYYJSYQOXTPL-SLPGGIOYSA-N isosorbide mononitrate Chemical compound [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-SLPGGIOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940099990 ogen Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
An enanthioselective process for preparing the compounds of for-mulas (I) and (II) from the prochi-ral ketone precursor of the alcohol of formula (I). The compounds of for-mulas (I) and (II) are thus obtained in substantially enantiomerically pure form by reducing the ketone with a borane reducing agent in the presence of a chiral oxazaborolidine catalyst.
Description
~10 95102585 ~ PCT/IB94/00062 ~1672~7 ENANTHIOSELECTIVE PREPARATION OF THIAZOLE DERIVATIYES
Back~round of the Invention This invention relates to a particularly useful process for preparing the 5 compounds of formulas (I) and (Il), ~Br (I) (II) in subsl~"lially enantiomerically pure form by enar,lios~l~ctively reducing the prochiral ketone of formula (Ill) o J~Br F3C ~ ~
~III) with a borane reducing agent in the plesence of an oxazaborolidine catalyst. Theoptically pure compounds of formulas (I) and (lI) are useful intermeri;-tes in the synthesis of useful ar,li-liabetic compounds of formula (IV), -WO95/02585 '?,~.6~ 2- PcT/Issllono6~
OH H
5F3 Cl~ O~C 0 0 H
( I V ) 10which are ~isclosed in U.S. 4,886,814, and which is incorporated herein by reference.
Summarv of the Invention The pl`~Selll invention provides a process for enat,liosele~ ely prepari~g the compound of formula (I) OH
15N~Br F3C~S~
(I) in suL sL~nlially enar,lioselectively pure form. The process of this invention CG" ",, i~es reacting the procl,i,~l ketone of formula (Ill), o J~B r F3C~
( I I I ) V0 95102585 ~ 2 ~ 7 PCT/IB94/00062 with a borane reducing agent in the presence of a chiral oxazaborolidine catalyst of the - formula (~/), )~
`B' 7 ~1 (V~
wherein R' is hydrogen, (C,-C8)alkyl, benzyl, heterocyclyl or phenyl optionally substituted independently with up to three (C1-C8)alkyl, (C1-C8)alkoxy or halo groups;
R2 and R3 are syn, are taken separately, and are each independeully (C1-C8)alkyl, benzyl, heterocyclyl or phenyl optionally sl~hstitl~ted with up to three (C1-C8)alkyl, (C1-5 C8)alkoxy or halo groups, provided that when R2 is CH3 and R3 is phenyl, R' is H, orwith a chiral oxazaborolidine catalyst of the formula (Vl), ) ~\
H ~B~0 (VI ) 25 wherein R' is as defined above and D is a cis-fused 4-6 membered c~rbo",oi)ocyclic ring oplioll&lly substituted indepel,derllly with up to three (C1-C8)alkyl, heterocyclyl or phenyl o,,lio, lal!y sl Ihstit~ Iteci independer,lly with up to three (C1-C8)alkyl, (C,-C8)alkoxy or halo groups; a cis-fused 6-9 membered carLobicyclic system optionally substituted i"dep~ndently with up to three (C,-C8)alkyl, heterocyclyl or phenyl o,,lionally substituted 30 indeper,de, Illy with up to three (C,-C8)alkyl, (C,-C8)alkoxy or halo groups; or a cis-fused WO 95/0258~ PCT/1~394/0006~
5 system hrlving the structure ~ wherein R~ and R' are each independently H, (C,-C8)alkyl, (C,-C8)alkoxy or halo, in a reaction inert solvent under a reaction inert ,osphere.
A pr~r~r,ed process of this invention is the above process wherein said oxazaborolidine catalyst is ~"~A~ C",H"3 ~
H N~B~o o r `B' H H
(VII) (VIII) A particularly pr~"ed pl~cess within the pr~fe,.ed process is the process wherein said reaction inert solvent is tetrahydrofuran, dioxane, diethyl ether, toluene or 25 ber,~ene; said reaction inert atmospher~ is nitrogen and said borane reducing agent is borane methylsulfide complex.
A more particularly prefer,ed process within the particularly pr~:~"~:d process is the process wherein said chiral oxazaborolidine catalyst is ,ur~par~d in situ prior to the ad.litiGn of said procl~i,al ketone of formula (Ill).
~O 95/02585 ~ 6 72~ ~ PCT/IBg4/00062 The present invention also provides a process for enantioselectively prepari"g the compound of the formula (Il), r 5 /~
F3 C~S~
(II) which co" ,pri~es prepari"g the compound of formula (1) as described l~erei. ,above and reacting said compound of formula (I) with a base to form the compound of formula (Il) in suL,sldnlidlly er,ar,liG",erically pure form.
Detailed Descli~,lion of the Invention The presenl invention provides a process for preparing the optically active compounds of formulas (I) and (Il) hereinabove in subslar,lidlly enarl~iGmerically pure form. The scheme for this process is shown in Scheme 1, below.
W O 95/0258~ PCT~B94/0006 chiral 1,2-disubstituted + borane reducing ( I I I ) aminoethanol agent O OH
)~Br Borane reduc i ng agen t N--A~Br F3C--~ c h i ral c atal y~ t F3C--~S~
(III) (I) Ba~e ,~
1~
F3C--~S~
(II) SCHEME I
The process of this invention is readily carried out. The con,pound of formula (I) is prepared in suL,~I~r,lially enantiomerically pure form via the reduction of the prochiral ketone, 4-bromoacetyl-2-trifluoromethylthia_ole (Ill).
In the reduction process of this invention, the precursor to the chiral 30 oxA~Ahor~,lidi"e catalyst, in the form of a chiral 1 ,2-dis~ ~hstituted aminoethanol derivative, is dissolved in a reaction inert solvent under a reaction inert atmosphere at ambient temperature. The chiral 1,2-~isl~hstih~ted amino-ethanol derivative can be chosen from among any of the 1 ,2-disl~hstih~ted aminoethanol derivatives which give rise to the chiral oxazaborolidine catalysts which are used in the process of this vo gs/02s85 21~ 728 7 PCT/IB94/00062 . ~ . ~
invention. However, pr~er,ed 1,2-disubstituted amino-ethanol derivatives are (lS, 2R)-(+)-2-amino-1,2-diphenylethanol and (lS, 2R)-(+)-r~orephedrine. The reaction inert solvents which are particularly pr~fer,ed include but are not limited to dioxane, 5 tetrahydrofuran, diethyl ether, toluene and benzene. More particularly pr~fened solvents are tetrahydrofuran and toluene. A suitable borane reducing agent is added to the reaction mixture and the reaction mixture is left at amL i~nt temperature for 2 to 24 hours. The borane reducing agent may be selectecl from borane methylsulfide complex and borane tetrahydrofuran complex, but most prerer"ad is borane 10 methylsulfide complex. Generally the chiral oxazaborolidine catalyst will have formed within 10-16 hours.
After the chiral oxazaborolidine catalyst has formed, the prochiral ketone of formula (Ill) is added to the reac~ion mixture at ambient ter"perdlure. The reaction reducing the ketone to the alcohol is yener~lly colrrleti within 10-15 minutes after 15 addition is cor, Ir'~te. I lo~Jer, occasionally a longer amount of time may be required to ensure complete reaction depending upon a variety of factors including the particular solvents chosen or amounts of materials used and so on. The reaction mixture is then cooled, generally to about 0C, and quenched by the careful addition of a protonsource, generally methanol. The compound of formula (I) is isolated accGI~Jing to the 20 slandard methods of organic chelr,i~,y.
Altematively, the reduction process of this invention can be carried out by reacting a prochiral ketone of the formula R4R5Co, wherein R4 and R5 are definedhereinbelow with a borane reducing agent in the presence of a chiral oxazaborolidine catalyst accor.li.,g to formula (\/) or formula (\/I). Said process results in the 25 enantioselective reduction of said prochiral ketone, such that only one of two possible alcohol enantiomers is formed in pl~fer~nce to the corlespond;ng enantiomer. Thedegree of enantio sele~,ti~rity which is obtained will vary depenJi"g upon the size of the R4 and R5 groups attached to the carbonyl group forming the prochiral ketone. When the R~ and Rs groups are similar in size, the degree of enanlioselection will be lower.
30 As the R4 and R5 groups become i"cleasi"yly ~ parate in size, the degree of enantio-selection will be greater. However, it should be under~lood that the size of the R4 and R5 groups is not the sole deler~"i"i"g factor affecting the degree of enantioselectivity achieved. Oldi.,arily, with prochiral ketones wherein R4 and R5 are at least moderately 2~85 ~ PCT/IB94/0006 dillerer,l in size, at least 90% of the desired enarlLio",er will be obtained. However, typically greater than 90% of the desired enantiomer is Gbta;"ed The prochiral ketone is dissolved in a suitable reaction inert solvent such as 5 toluene, diethyl ether, dioxane, tetrahydrofuran or the like. r, ~t " ed is tetrahydrofuran.
A catalytically effective amount of a chiral oxazaborolidine compound of formula (V) or formula ~/I) is added to the reaction mixture at from about -78C to about room ter"peraLure, ~l~r~lerably at room temperature; howevcr, the pl~er.ed temperature will vary depending upon the particular borane reducing agent being used. The pr~lel.ed 10 amount of said catalyst is about 5-10 mole % with r espect to said ketone. The reaction mixture is then treated slowly with about 4.2 hydride equivalents of a borane reducing agent such as borane dimethylsulfide complex, borane tetrahydrofuran complex, catecholborane or the like. When the prochiral ketone cor,Lui,,s an R4 or R5 group which bears a borane-coordinating functionality, addiLiol,al hydride equivalents of 15 reducing agent are necess~y. Generally pr~far,ed for its ease of use is borane dimethylsulfide complex. Generally the reducing agent is added at a rate which mod~ t~s the rate of the catalytic reduction. The ~eacLiGn is sometillles cGr, ~!~ e as soon as all of the reducing agent has been added, as can be determined by monit~"i"g the course of the reaction via thin layer c:hr~,l"alography according to the sLand.~.d 20 pra~,~Lice of organic ch~ l, y. I low_vcr, occasionally it will be desi, al~le to allow the reaction mixture to stir for longer periods of time such as overnight, or to heat the Fea~,1iGn mixture to temperatures of up to 40C to 65C in order to ensure completion of the reaction. Additionally, with some sub~L,ales and reducing agents, it may be n ecessA~ y to stir the reaction mixture at -78C for a lengthy period of time such as 16 25 hours. Ordinarily the reaction mixture is stirred at about room temper~lure for about fifteen minutes. The ter"pe,aLure of reactiGI- mixture is then ~lju~ted to 0C and quenched with a proton source. Said proton source, usually a lower alkanol such as ",~Lt,anol, is added slowly to control the exothermic rea~LiGn. The product is isGl~ d by removing the solvent in vacuo fcl'~wed by pa,liliol,i.,g between an ~g~,ic solvent 30 andan~qlleousacidf~llcvl~dbysepar~LionoflayersandplJ,ilicaLionaccordingtothe ~Lal.dar:l tecl,n, les of or~anic chelni~LIy.
The compound of formula (Il) of this plocess is also readily prepared. The compound of formula (I) is di~solved in aqueous base and vigorously stirred. The,ur~,,ed base is sodium hydroxide, however other bases such as potassium hydroxide ~0 9S/0~585 , ,, ~7 and potassium t-butoxide may also be utilized. The debr-""il,ation and cyclization of the compound of formula (I) to the epoxide of formula (Il) is ~r~uled rapidly and without racer"i~alion of the chiral center. Generally the reaction is CG~ lele within 5 to 10 5 minutes, however the reaction may require longer periods depending upon a variety of factors including sl.el,ylll of base, nature of base, amount of ~"~lle,ials used and so on.
After the epoxide is formed, the epoxide is isolaled from the re&ctiGI~ mixture utilizing well-known methods of organic cher"i~l~y.
The prochiral ketone starting mcl~:,ial for the process of this reaction is prepared by the method disclosed in U.S. Patent 4,886,814. The utility of these compounds as intermediates in the process for the preparclion of the antidiabetic cGi"pound of formula (IV) is also described therein.
The chiral 1 ,2-~isl ~hstihlted aminoethanol derivatives are gener_"y readily available from commercial sources such as Aldrich or Sigma. Where the chiral 1,2-15 ~iSI ~hstit~ ~ted aminoethanol derivative is not readily a\~ 1 e, said erythro amir,oeth&r,olderivatives are pl~pared by methods well known to those of ordinary skill in the art, such as provided by Reetz et al., Angew. Chemie Int. Ed. Eng., 26, 1987, 114143 and Matsunaga et al., T~t-cll)e.l~on Letters, 32, 1991, 7715-18.
The fcllo/,l:.,g terms and ph,ases, when used herein and in the appendant 20 claims, are defined as follows:
1. "Alkyl" means a br~nched or unbranched saturated hydrocarbon group containing the specified number of carbon atoms, e.g., C,-C8. Examples include, but are not limited to methyl, ethyl, isopropyl, n-butyl, t-butyl and the like.
2. "Alkoxy" means a br~nched or ~" Ibran.~hed saturated hydrocarbon 25 containing the specified number of carbon atoms and a single oxygen atom by which said hydrocarbon is ~,llL~ched to a central backL,ol-e. Exa",r'es include, but are not limited to methoxy, ethoxy and the like.
Back~round of the Invention This invention relates to a particularly useful process for preparing the 5 compounds of formulas (I) and (Il), ~Br (I) (II) in subsl~"lially enantiomerically pure form by enar,lios~l~ctively reducing the prochiral ketone of formula (Ill) o J~Br F3C ~ ~
~III) with a borane reducing agent in the plesence of an oxazaborolidine catalyst. Theoptically pure compounds of formulas (I) and (lI) are useful intermeri;-tes in the synthesis of useful ar,li-liabetic compounds of formula (IV), -WO95/02585 '?,~.6~ 2- PcT/Issllono6~
OH H
5F3 Cl~ O~C 0 0 H
( I V ) 10which are ~isclosed in U.S. 4,886,814, and which is incorporated herein by reference.
Summarv of the Invention The pl`~Selll invention provides a process for enat,liosele~ ely prepari~g the compound of formula (I) OH
15N~Br F3C~S~
(I) in suL sL~nlially enar,lioselectively pure form. The process of this invention CG" ",, i~es reacting the procl,i,~l ketone of formula (Ill), o J~B r F3C~
( I I I ) V0 95102585 ~ 2 ~ 7 PCT/IB94/00062 with a borane reducing agent in the presence of a chiral oxazaborolidine catalyst of the - formula (~/), )~
`B' 7 ~1 (V~
wherein R' is hydrogen, (C,-C8)alkyl, benzyl, heterocyclyl or phenyl optionally substituted independently with up to three (C1-C8)alkyl, (C1-C8)alkoxy or halo groups;
R2 and R3 are syn, are taken separately, and are each independeully (C1-C8)alkyl, benzyl, heterocyclyl or phenyl optionally sl~hstitl~ted with up to three (C1-C8)alkyl, (C1-5 C8)alkoxy or halo groups, provided that when R2 is CH3 and R3 is phenyl, R' is H, orwith a chiral oxazaborolidine catalyst of the formula (Vl), ) ~\
H ~B~0 (VI ) 25 wherein R' is as defined above and D is a cis-fused 4-6 membered c~rbo",oi)ocyclic ring oplioll&lly substituted indepel,derllly with up to three (C1-C8)alkyl, heterocyclyl or phenyl o,,lio, lal!y sl Ihstit~ Iteci independer,lly with up to three (C1-C8)alkyl, (C,-C8)alkoxy or halo groups; a cis-fused 6-9 membered carLobicyclic system optionally substituted i"dep~ndently with up to three (C,-C8)alkyl, heterocyclyl or phenyl o,,lionally substituted 30 indeper,de, Illy with up to three (C,-C8)alkyl, (C,-C8)alkoxy or halo groups; or a cis-fused WO 95/0258~ PCT/1~394/0006~
5 system hrlving the structure ~ wherein R~ and R' are each independently H, (C,-C8)alkyl, (C,-C8)alkoxy or halo, in a reaction inert solvent under a reaction inert ,osphere.
A pr~r~r,ed process of this invention is the above process wherein said oxazaborolidine catalyst is ~"~A~ C",H"3 ~
H N~B~o o r `B' H H
(VII) (VIII) A particularly pr~"ed pl~cess within the pr~fe,.ed process is the process wherein said reaction inert solvent is tetrahydrofuran, dioxane, diethyl ether, toluene or 25 ber,~ene; said reaction inert atmospher~ is nitrogen and said borane reducing agent is borane methylsulfide complex.
A more particularly prefer,ed process within the particularly pr~:~"~:d process is the process wherein said chiral oxazaborolidine catalyst is ,ur~par~d in situ prior to the ad.litiGn of said procl~i,al ketone of formula (Ill).
~O 95/02585 ~ 6 72~ ~ PCT/IBg4/00062 The present invention also provides a process for enantioselectively prepari"g the compound of the formula (Il), r 5 /~
F3 C~S~
(II) which co" ,pri~es prepari"g the compound of formula (1) as described l~erei. ,above and reacting said compound of formula (I) with a base to form the compound of formula (Il) in suL,sldnlidlly er,ar,liG",erically pure form.
Detailed Descli~,lion of the Invention The presenl invention provides a process for preparing the optically active compounds of formulas (I) and (Il) hereinabove in subslar,lidlly enarl~iGmerically pure form. The scheme for this process is shown in Scheme 1, below.
W O 95/0258~ PCT~B94/0006 chiral 1,2-disubstituted + borane reducing ( I I I ) aminoethanol agent O OH
)~Br Borane reduc i ng agen t N--A~Br F3C--~ c h i ral c atal y~ t F3C--~S~
(III) (I) Ba~e ,~
1~
F3C--~S~
(II) SCHEME I
The process of this invention is readily carried out. The con,pound of formula (I) is prepared in suL,~I~r,lially enantiomerically pure form via the reduction of the prochiral ketone, 4-bromoacetyl-2-trifluoromethylthia_ole (Ill).
In the reduction process of this invention, the precursor to the chiral 30 oxA~Ahor~,lidi"e catalyst, in the form of a chiral 1 ,2-dis~ ~hstituted aminoethanol derivative, is dissolved in a reaction inert solvent under a reaction inert atmosphere at ambient temperature. The chiral 1,2-~isl~hstih~ted amino-ethanol derivative can be chosen from among any of the 1 ,2-disl~hstih~ted aminoethanol derivatives which give rise to the chiral oxazaborolidine catalysts which are used in the process of this vo gs/02s85 21~ 728 7 PCT/IB94/00062 . ~ . ~
invention. However, pr~er,ed 1,2-disubstituted amino-ethanol derivatives are (lS, 2R)-(+)-2-amino-1,2-diphenylethanol and (lS, 2R)-(+)-r~orephedrine. The reaction inert solvents which are particularly pr~fer,ed include but are not limited to dioxane, 5 tetrahydrofuran, diethyl ether, toluene and benzene. More particularly pr~fened solvents are tetrahydrofuran and toluene. A suitable borane reducing agent is added to the reaction mixture and the reaction mixture is left at amL i~nt temperature for 2 to 24 hours. The borane reducing agent may be selectecl from borane methylsulfide complex and borane tetrahydrofuran complex, but most prerer"ad is borane 10 methylsulfide complex. Generally the chiral oxazaborolidine catalyst will have formed within 10-16 hours.
After the chiral oxazaborolidine catalyst has formed, the prochiral ketone of formula (Ill) is added to the reac~ion mixture at ambient ter"perdlure. The reaction reducing the ketone to the alcohol is yener~lly colrrleti within 10-15 minutes after 15 addition is cor, Ir'~te. I lo~Jer, occasionally a longer amount of time may be required to ensure complete reaction depending upon a variety of factors including the particular solvents chosen or amounts of materials used and so on. The reaction mixture is then cooled, generally to about 0C, and quenched by the careful addition of a protonsource, generally methanol. The compound of formula (I) is isolated accGI~Jing to the 20 slandard methods of organic chelr,i~,y.
Altematively, the reduction process of this invention can be carried out by reacting a prochiral ketone of the formula R4R5Co, wherein R4 and R5 are definedhereinbelow with a borane reducing agent in the presence of a chiral oxazaborolidine catalyst accor.li.,g to formula (\/) or formula (\/I). Said process results in the 25 enantioselective reduction of said prochiral ketone, such that only one of two possible alcohol enantiomers is formed in pl~fer~nce to the corlespond;ng enantiomer. Thedegree of enantio sele~,ti~rity which is obtained will vary depenJi"g upon the size of the R4 and R5 groups attached to the carbonyl group forming the prochiral ketone. When the R~ and Rs groups are similar in size, the degree of enanlioselection will be lower.
30 As the R4 and R5 groups become i"cleasi"yly ~ parate in size, the degree of enantio-selection will be greater. However, it should be under~lood that the size of the R4 and R5 groups is not the sole deler~"i"i"g factor affecting the degree of enantioselectivity achieved. Oldi.,arily, with prochiral ketones wherein R4 and R5 are at least moderately 2~85 ~ PCT/IB94/0006 dillerer,l in size, at least 90% of the desired enarlLio",er will be obtained. However, typically greater than 90% of the desired enantiomer is Gbta;"ed The prochiral ketone is dissolved in a suitable reaction inert solvent such as 5 toluene, diethyl ether, dioxane, tetrahydrofuran or the like. r, ~t " ed is tetrahydrofuran.
A catalytically effective amount of a chiral oxazaborolidine compound of formula (V) or formula ~/I) is added to the reaction mixture at from about -78C to about room ter"peraLure, ~l~r~lerably at room temperature; howevcr, the pl~er.ed temperature will vary depending upon the particular borane reducing agent being used. The pr~lel.ed 10 amount of said catalyst is about 5-10 mole % with r espect to said ketone. The reaction mixture is then treated slowly with about 4.2 hydride equivalents of a borane reducing agent such as borane dimethylsulfide complex, borane tetrahydrofuran complex, catecholborane or the like. When the prochiral ketone cor,Lui,,s an R4 or R5 group which bears a borane-coordinating functionality, addiLiol,al hydride equivalents of 15 reducing agent are necess~y. Generally pr~far,ed for its ease of use is borane dimethylsulfide complex. Generally the reducing agent is added at a rate which mod~ t~s the rate of the catalytic reduction. The ~eacLiGn is sometillles cGr, ~!~ e as soon as all of the reducing agent has been added, as can be determined by monit~"i"g the course of the reaction via thin layer c:hr~,l"alography according to the sLand.~.d 20 pra~,~Lice of organic ch~ l, y. I low_vcr, occasionally it will be desi, al~le to allow the reaction mixture to stir for longer periods of time such as overnight, or to heat the Fea~,1iGn mixture to temperatures of up to 40C to 65C in order to ensure completion of the reaction. Additionally, with some sub~L,ales and reducing agents, it may be n ecessA~ y to stir the reaction mixture at -78C for a lengthy period of time such as 16 25 hours. Ordinarily the reaction mixture is stirred at about room temper~lure for about fifteen minutes. The ter"pe,aLure of reactiGI- mixture is then ~lju~ted to 0C and quenched with a proton source. Said proton source, usually a lower alkanol such as ",~Lt,anol, is added slowly to control the exothermic rea~LiGn. The product is isGl~ d by removing the solvent in vacuo fcl'~wed by pa,liliol,i.,g between an ~g~,ic solvent 30 andan~qlleousacidf~llcvl~dbysepar~LionoflayersandplJ,ilicaLionaccordingtothe ~Lal.dar:l tecl,n, les of or~anic chelni~LIy.
The compound of formula (Il) of this plocess is also readily prepared. The compound of formula (I) is di~solved in aqueous base and vigorously stirred. The,ur~,,ed base is sodium hydroxide, however other bases such as potassium hydroxide ~0 9S/0~585 , ,, ~7 and potassium t-butoxide may also be utilized. The debr-""il,ation and cyclization of the compound of formula (I) to the epoxide of formula (Il) is ~r~uled rapidly and without racer"i~alion of the chiral center. Generally the reaction is CG~ lele within 5 to 10 5 minutes, however the reaction may require longer periods depending upon a variety of factors including sl.el,ylll of base, nature of base, amount of ~"~lle,ials used and so on.
After the epoxide is formed, the epoxide is isolaled from the re&ctiGI~ mixture utilizing well-known methods of organic cher"i~l~y.
The prochiral ketone starting mcl~:,ial for the process of this reaction is prepared by the method disclosed in U.S. Patent 4,886,814. The utility of these compounds as intermediates in the process for the preparclion of the antidiabetic cGi"pound of formula (IV) is also described therein.
The chiral 1 ,2-~isl ~hstihlted aminoethanol derivatives are gener_"y readily available from commercial sources such as Aldrich or Sigma. Where the chiral 1,2-15 ~iSI ~hstit~ ~ted aminoethanol derivative is not readily a\~ 1 e, said erythro amir,oeth&r,olderivatives are pl~pared by methods well known to those of ordinary skill in the art, such as provided by Reetz et al., Angew. Chemie Int. Ed. Eng., 26, 1987, 114143 and Matsunaga et al., T~t-cll)e.l~on Letters, 32, 1991, 7715-18.
The fcllo/,l:.,g terms and ph,ases, when used herein and in the appendant 20 claims, are defined as follows:
1. "Alkyl" means a br~nched or unbranched saturated hydrocarbon group containing the specified number of carbon atoms, e.g., C,-C8. Examples include, but are not limited to methyl, ethyl, isopropyl, n-butyl, t-butyl and the like.
2. "Alkoxy" means a br~nched or ~" Ibran.~hed saturated hydrocarbon 25 containing the specified number of carbon atoms and a single oxygen atom by which said hydrocarbon is ~,llL~ched to a central backL,ol-e. Exa",r'es include, but are not limited to methoxy, ethoxy and the like.
3. H~lel~cyclylR means a 5- or 6-membered aro",~lic group containing up to three heteroatoms, each of said h~lel~loms selected from N, 0 and S and which30 may be optionally benzo-fused, said heterocyclyl group being optionally s~hstihlted independently with up to three (C,-C8)alkyl, (C,-C8)alkoxy or halo groups.
4. A '`,~rochi.~l ketone", denoted by R~R5Co, is a ketone in which R4 and R5 are non-identical, so that the secondary alcohol recl~ction product R~R5CHoH has a chiral center at the alcohol carbon. For cyclic pl~Jchi.~l ketones, it is u"der-~lood that 5 c~ PCT/IB94/0006~
R4 and R5 are taken together, forming a ring including the ketone, and that the ring so formed has no plane of symmetry across a plane drawn perpendicular to the plane CGI llni. Iil l9 the carbonyl group and the two carbon atoms allached directly thereto, said 5 plane containing both the carbon and oxygen atoms of the carbonyl group as points therein.
7. Reaction inert solvent means a solvent which does not interact with the reaclnl lls, il llt:r, I ,e~ s or products in such a way that adversely affects the yield of the desired products.
8. "Syn" means that the s~hstitllents sllhstitllted on adjacent ring carbon atoms are located on the same side of a plane which enco"~p~cses the bond between said carbon atoms and the bonds by which each of said carbon atoms are attached to the ring.
9. ~n6riliGIneric excess", or e.e., is the excess of one of two ent~l,lio",~
over the other, usually ex~ ssed as a percentage, i.e., a 90% e.e. reflects the presence of 95% of one enar,liol"er and 5% of the other in the ",~l~rial in question.
10. ~Ambient tel "peral.lre" means the temperature of the immediate eAI~ al environment surrounding the reaction flask. This tel"pelalure is usually room temperature (20-25C).
11. In situ is the reaction cGr,dit;on v~;,erei., the chiral oxa~aborvlidines of formula (\/) or formula (\/I) of the invention are formed from the precursor aminc~'c ~ hol and borane. The prochiral ketone is added after the o.Y~ hor~ '.dine is generated. The chiral o.~ horolidines of the invention are not isol-~ed under these cor,diliol ,s.
12. "ne&~,tion inert al",osphere" means a gas which does not illlernct with 25 the r~actn"l~ r,nel l; '.es or products in such a way that adversely affects th2 yield of the desired products.
The presel,l invention is illustrated by the f~ v.;.lg eAtll~l; 18s. I low_vcr, it should be understood that the invention is not limited to th~ spe~ c details of these examples. All reactions are conducted under an inert ~I",osphe,t:, such as nil,ogen 30 or argon, unless otherwise specified. All solvents are anhydrous, i.e., contain such a small amount of water that said water does not interact with the r eage, ll~, intermediates or products in such a way that adversely affects the yield of the desired products.
Where used herein, '~HF" means tetrahydrofuran.
~?1 6 7~8 7 Example One (S)-Oxiranvl-2-trifluorol "~thylthiazole.
A. (S)-4-(2-Bromo-1 -hydroxyethyl)-2-trifluorol "ethyllhia~cl~. To atetrahydrofuran (55mL) solution of (1S, 2R)-(+)-2-amino-1,2-diphenylethanol (586mg, 2.75mmol, 0.05 equivalents based on bromoketone) under a nitrogen atmosphere was added neat borane methylsulfide complex (Aldrich, ~lOM, 7.70mL, 77mmol, 1.4 equivalents based on bromoketone) all at once and allowed to stand 16hrs. (EIMS) M+ 223.1159 (Calcd 223.1168). Blu~oketone lll, (15.0g, 54.7mmol, 1.0 equivalent) in tetrahydrofuran(28mL) was added dropwise over 1 hr at 25C. Fifteen minutes after the addiliGn was complete the starting ketone was consumed, the raa 1ion was cooled to 0C, quenched with r"~tl,anol (55mL), and stirred overnight. The solvents were removed under vacuum, toluene (140mL) was added to the residue, and the organic phase was washed successively with pH4 phosphate buffer (140mL), water (140mL) and treated15 with magnesium sulfate. Eiltlalion and removal of the solvent under vacuum a~urded the chiral alcohol as a pale yellow oil (13.58g, 90% mass balance, 94%ee).
B. (S)-Oxiranyl-2-trifluoromethylll _~le. A~ueo~-s sodium hydroxide (4N, 12.52mL) was added to the neat oil (13.42g) obl~i"ed ih A. above with vigorous stirring.
After 9 min. methylene chloride (lOOmL) and water (lOOmL) were added, the phases20 were sep~ ~led, and the ~queous phase washed with water (3 x 100mL) and dried with magnesium sulfate. rill~alion and removal of the solvent under vacuum ar~u,~Jed the crude chiral epoxide as an off white liquid, 9.35g. Distillation of 8.83g of the crude product at 4mmHg/boiling point 42~4C yielded 6.99g (70% overall from the bromoketone) of the chiral epoxide as a cc!orless oil.
Example Two (S)-4-(2-Bromo-1 -hvdroxvethyl)-2-trifluoromethylll ,' - le .
To a tetrahydrofuran (lOmL) solution of (lS, 2R)-(+)-nGrephedli"e (76mg, 0.5mmol) under a nil~oyen al",osphere was added neat borane methylsulfide complex (1 OM,1.4mL,14mmole) at ambient temperature (20-25C) and the reaction was allowed to stand for 16 hrs. Bromoketone lll, (2.74g, 10mmol) in tetrahydrofuran (5mL) was added dlùpJl:se over 1 hr, the reaction stirred for 15 min after the addition was cGm,~le~ts, then cooled to 0C and quenched with ",~tl,anol (lOmL). The quenchedI ~a~,1ion was stirred for 18hr, the solvents were removed under vacuum and methylene chloride (25mL) was added. The Glyanic phase was washed s~ccessiv01y with pH4 phospl)ate buffer (25mL), water (25mL), and dried with rllayllesium sulfate. After WO 95/02585 PCT/IB94/0006~
~6'~ 12-filtering, the solvent was removed under vacuum to afford the (S) alcohol 2.24g as a yellow oil (83%, 84%ee).
Example Three (Sl-Oxiranyl-2-trifluoro" ,~lh~,lll, ~ - le A. (S)-4-(2-Bromo-1 -hydroxyethyl)-2-trifluor~,l "~thylll ,i~zoie. Reduction intoluene and cycli~lion to the chiral epoxicle To a toluene (41 mL) solution of (1 S, 2R)-2-amino 1,2-diphenyl~tl,anol (438mg, 2mmol, 0.05 equivalents based on bromol~etone) under a nitrogen atmosphere was added neat borane methylsulfide cc mr\le: (Aldrich, ~lOM, 5.80mL, 58mmol, 1.4 equivalents based on Lru,,,oketone) all at once and allowed to stand 16 hrs. Blu~ol~etone ((Ill), 11.319, 41mmol, 1.0 equivalent) in toluene (21mL) was added dl opv.~; ~ over 1 hr at 25C. Fifteen minutes after the addiliol, was co" ,, iet the ~ .li"g ketone was consumed, the rea~,1ion was cooled to 0C, quenched with methanol (41mL), and stirred overnight. The solvents were removed under vacuum, toluene (100mL) added to the residue, the organic phase washed successively withueous sulfuric acid (1 M, 50mL), water (100mL), and treated with magnesium sulfate.
Removal of the solvent under vacuum a~urded the chiral alcohol as a pale yellow oil (10.849, 95% mass balance, 90%ee).
B. (S)-Oxiranyl-2-trifluoromethyl lhi~ol~. Aq~eo~s sodium hyd~ùxic-ie (4N, 10.53mL) was added to the neat oil (10.84g) with vigorous stirring. After 10 min., toluene (84mL) and water (84mL) were added, the phases separ~led, the ~ql~eous phase washed with water (3 X 84mL) and dried with magnesium sulfate. Removai of the solvent under vacuum &~orded the crude chiral epoxide as a off orange liquid, 6.509. Distillation of 6.079 of the crude product at 4mmHg/boiling point 42-44Cyielded 4.659 (61% overall from the bromoketone) of the chiral epoxide as a ~colerless oil.
R4 and R5 are taken together, forming a ring including the ketone, and that the ring so formed has no plane of symmetry across a plane drawn perpendicular to the plane CGI llni. Iil l9 the carbonyl group and the two carbon atoms allached directly thereto, said 5 plane containing both the carbon and oxygen atoms of the carbonyl group as points therein.
7. Reaction inert solvent means a solvent which does not interact with the reaclnl lls, il llt:r, I ,e~ s or products in such a way that adversely affects the yield of the desired products.
8. "Syn" means that the s~hstitllents sllhstitllted on adjacent ring carbon atoms are located on the same side of a plane which enco"~p~cses the bond between said carbon atoms and the bonds by which each of said carbon atoms are attached to the ring.
9. ~n6riliGIneric excess", or e.e., is the excess of one of two ent~l,lio",~
over the other, usually ex~ ssed as a percentage, i.e., a 90% e.e. reflects the presence of 95% of one enar,liol"er and 5% of the other in the ",~l~rial in question.
10. ~Ambient tel "peral.lre" means the temperature of the immediate eAI~ al environment surrounding the reaction flask. This tel"pelalure is usually room temperature (20-25C).
11. In situ is the reaction cGr,dit;on v~;,erei., the chiral oxa~aborvlidines of formula (\/) or formula (\/I) of the invention are formed from the precursor aminc~'c ~ hol and borane. The prochiral ketone is added after the o.Y~ hor~ '.dine is generated. The chiral o.~ horolidines of the invention are not isol-~ed under these cor,diliol ,s.
12. "ne&~,tion inert al",osphere" means a gas which does not illlernct with 25 the r~actn"l~ r,nel l; '.es or products in such a way that adversely affects th2 yield of the desired products.
The presel,l invention is illustrated by the f~ v.;.lg eAtll~l; 18s. I low_vcr, it should be understood that the invention is not limited to th~ spe~ c details of these examples. All reactions are conducted under an inert ~I",osphe,t:, such as nil,ogen 30 or argon, unless otherwise specified. All solvents are anhydrous, i.e., contain such a small amount of water that said water does not interact with the r eage, ll~, intermediates or products in such a way that adversely affects the yield of the desired products.
Where used herein, '~HF" means tetrahydrofuran.
~?1 6 7~8 7 Example One (S)-Oxiranvl-2-trifluorol "~thylthiazole.
A. (S)-4-(2-Bromo-1 -hydroxyethyl)-2-trifluorol "ethyllhia~cl~. To atetrahydrofuran (55mL) solution of (1S, 2R)-(+)-2-amino-1,2-diphenylethanol (586mg, 2.75mmol, 0.05 equivalents based on bromoketone) under a nitrogen atmosphere was added neat borane methylsulfide complex (Aldrich, ~lOM, 7.70mL, 77mmol, 1.4 equivalents based on bromoketone) all at once and allowed to stand 16hrs. (EIMS) M+ 223.1159 (Calcd 223.1168). Blu~oketone lll, (15.0g, 54.7mmol, 1.0 equivalent) in tetrahydrofuran(28mL) was added dropwise over 1 hr at 25C. Fifteen minutes after the addiliGn was complete the starting ketone was consumed, the raa 1ion was cooled to 0C, quenched with r"~tl,anol (55mL), and stirred overnight. The solvents were removed under vacuum, toluene (140mL) was added to the residue, and the organic phase was washed successively with pH4 phosphate buffer (140mL), water (140mL) and treated15 with magnesium sulfate. Eiltlalion and removal of the solvent under vacuum a~urded the chiral alcohol as a pale yellow oil (13.58g, 90% mass balance, 94%ee).
B. (S)-Oxiranyl-2-trifluoromethylll _~le. A~ueo~-s sodium hydroxide (4N, 12.52mL) was added to the neat oil (13.42g) obl~i"ed ih A. above with vigorous stirring.
After 9 min. methylene chloride (lOOmL) and water (lOOmL) were added, the phases20 were sep~ ~led, and the ~queous phase washed with water (3 x 100mL) and dried with magnesium sulfate. rill~alion and removal of the solvent under vacuum ar~u,~Jed the crude chiral epoxide as an off white liquid, 9.35g. Distillation of 8.83g of the crude product at 4mmHg/boiling point 42~4C yielded 6.99g (70% overall from the bromoketone) of the chiral epoxide as a cc!orless oil.
Example Two (S)-4-(2-Bromo-1 -hvdroxvethyl)-2-trifluoromethylll ,' - le .
To a tetrahydrofuran (lOmL) solution of (lS, 2R)-(+)-nGrephedli"e (76mg, 0.5mmol) under a nil~oyen al",osphere was added neat borane methylsulfide complex (1 OM,1.4mL,14mmole) at ambient temperature (20-25C) and the reaction was allowed to stand for 16 hrs. Bromoketone lll, (2.74g, 10mmol) in tetrahydrofuran (5mL) was added dlùpJl:se over 1 hr, the reaction stirred for 15 min after the addition was cGm,~le~ts, then cooled to 0C and quenched with ",~tl,anol (lOmL). The quenchedI ~a~,1ion was stirred for 18hr, the solvents were removed under vacuum and methylene chloride (25mL) was added. The Glyanic phase was washed s~ccessiv01y with pH4 phospl)ate buffer (25mL), water (25mL), and dried with rllayllesium sulfate. After WO 95/02585 PCT/IB94/0006~
~6'~ 12-filtering, the solvent was removed under vacuum to afford the (S) alcohol 2.24g as a yellow oil (83%, 84%ee).
Example Three (Sl-Oxiranyl-2-trifluoro" ,~lh~,lll, ~ - le A. (S)-4-(2-Bromo-1 -hydroxyethyl)-2-trifluor~,l "~thylll ,i~zoie. Reduction intoluene and cycli~lion to the chiral epoxicle To a toluene (41 mL) solution of (1 S, 2R)-2-amino 1,2-diphenyl~tl,anol (438mg, 2mmol, 0.05 equivalents based on bromol~etone) under a nitrogen atmosphere was added neat borane methylsulfide cc mr\le: (Aldrich, ~lOM, 5.80mL, 58mmol, 1.4 equivalents based on Lru,,,oketone) all at once and allowed to stand 16 hrs. Blu~ol~etone ((Ill), 11.319, 41mmol, 1.0 equivalent) in toluene (21mL) was added dl opv.~; ~ over 1 hr at 25C. Fifteen minutes after the addiliol, was co" ,, iet the ~ .li"g ketone was consumed, the rea~,1ion was cooled to 0C, quenched with methanol (41mL), and stirred overnight. The solvents were removed under vacuum, toluene (100mL) added to the residue, the organic phase washed successively withueous sulfuric acid (1 M, 50mL), water (100mL), and treated with magnesium sulfate.
Removal of the solvent under vacuum a~urded the chiral alcohol as a pale yellow oil (10.849, 95% mass balance, 90%ee).
B. (S)-Oxiranyl-2-trifluoromethyl lhi~ol~. Aq~eo~s sodium hyd~ùxic-ie (4N, 10.53mL) was added to the neat oil (10.84g) with vigorous stirring. After 10 min., toluene (84mL) and water (84mL) were added, the phases separ~led, the ~ql~eous phase washed with water (3 X 84mL) and dried with magnesium sulfate. Removai of the solvent under vacuum &~orded the crude chiral epoxide as a off orange liquid, 6.509. Distillation of 6.079 of the crude product at 4mmHg/boiling point 42-44Cyielded 4.659 (61% overall from the bromoketone) of the chiral epoxide as a ~colerless oil.
Claims (16)
1. A process for enantioselectively preparing the compound of the formula (I), (I) in substantially enantiomerically pure form, comprising:
reacting the prochiral ketone of formula (III), (III) with a borane reducing agent in the presence of a chiral oxazaborolidine catalyst of the formula (V) (V) wherein R1 is hydrogen, (C1-C8)alkyl, benzyl, heterocyclyl or phenyl optionally substituted independently with up to three (C1-C8)alkyl, (C1-C8)alkoxy or halo groups;
R2 and R3 are syn, are taken separately, and are each independently (C1-C8)alkyl, benzyl, heterocyclyl or phenyl optionally substituted with up to three (C1-C8)alkyl, (C1-C8)alkoxy or halo groups, provided that when R2 is CH3 and R3 is phenyl, R1 is H, or with a chiral oxazaborolidine catalyst of the formula (VI), , (VI) wherein R1 is as defined above and D is a cis-fused 4-6 membered carbomonocyclicring optionally substituted independently with up to three (C1-C8)alkyl, heterocyclyl or phenyl optionally substituted independently with up to three (C1-C8)alkyl, (C1-C8)alkoxy or halo groups; a cis-fused 6-9 membered carbobicyclic system optionally substituted independently with up to three (C1-C8)alkyl, heterocyclyl or phenyl optionally substituted independently with up to three (C1-C8)alkyl, (C1-C8)alkoxy or halo groups; or a cis-fused system having the structure , wherein R6 and R7 are each independently H, (C1-C8)alkyl, (C1-C8)alkoxy or halo, in a reaction inert solvent under a reaction inert atmosphere.
reacting the prochiral ketone of formula (III), (III) with a borane reducing agent in the presence of a chiral oxazaborolidine catalyst of the formula (V) (V) wherein R1 is hydrogen, (C1-C8)alkyl, benzyl, heterocyclyl or phenyl optionally substituted independently with up to three (C1-C8)alkyl, (C1-C8)alkoxy or halo groups;
R2 and R3 are syn, are taken separately, and are each independently (C1-C8)alkyl, benzyl, heterocyclyl or phenyl optionally substituted with up to three (C1-C8)alkyl, (C1-C8)alkoxy or halo groups, provided that when R2 is CH3 and R3 is phenyl, R1 is H, or with a chiral oxazaborolidine catalyst of the formula (VI), , (VI) wherein R1 is as defined above and D is a cis-fused 4-6 membered carbomonocyclicring optionally substituted independently with up to three (C1-C8)alkyl, heterocyclyl or phenyl optionally substituted independently with up to three (C1-C8)alkyl, (C1-C8)alkoxy or halo groups; a cis-fused 6-9 membered carbobicyclic system optionally substituted independently with up to three (C1-C8)alkyl, heterocyclyl or phenyl optionally substituted independently with up to three (C1-C8)alkyl, (C1-C8)alkoxy or halo groups; or a cis-fused system having the structure , wherein R6 and R7 are each independently H, (C1-C8)alkyl, (C1-C8)alkoxy or halo, in a reaction inert solvent under a reaction inert atmosphere.
2. A process according to claim 1 wherein said oxazaborolidine catalyst is or .
(VII) (VIII)
(VII) (VIII)
3. A process according to claim 2 wherein said reaction inert solvent is tetrahydrofuran, dioxane, diethyl ether, toluene or benzene.
4. A process according to claim 3 wherein said reaction inert atmosphere is nitrogen, said borane reducing agent is borane methylsulfide complex and the temperature of the reaction mixture is maintained at ambient temperature.
5. A process according to claim 4 wherein said reaction inert solvent is tetrahydrofuran.
6. A process according to claim 5 wherein said chiral oxazaborolidine catalyst is prepared in situ by reacting said borane methylsulfide complex with (1S, 2R)-2-amino-1,2-amino-1,2-diphenylethanol prior to the addition of said prochiral ketone.
7. A process according to claim 5 wherein said chiral oxazaborolidine catalyst is prepared in situ by reacting said borane methylsulfide complex with (1S, 2R)-(+)-norephedrine prior to the addition of said prochiral ketone.
8. A process according to claim 4 wherein said reaction inert solvent is toluene.
9. A process according to claim 8 wherein said chiral oxazaborolidine catalyst is prepared in situ by reacting said borane methylsulfide complex with (1S, 2R)-2-amino-1,2-diphenylethanol prior to the addition of said prochiral ketone.
10. A process according to claim 8 wherein said chiral oxazaborolidine catalyst is prepared in situ by reacting said borane methylsulfide complex with (1S, 2R)-(+)-norephedrine prior to the addition of said prochiral ketone.
11. A process for preparing the compound of formula (II), (II) comprising enantioselectively preparing the compound of formula (I) according to the process of claim 1 and reacting said compound of formula (I) with a base to form said compound of formula (II).
12. A process according to claim 11 wherein said base is sodium hydroxide.
13. A process according to claim 12 wherein said borane reducing agent is borane methylsulfide complex, said reaction inert solvent is toluene, said reaction inert atmosphere is nitrogen, the temperature of the reaction mixture is ambient temperature and the chiral oxazaborolidine catalyst is prepared in situ by reacting said borane methylsulfide complex with (1S, 2R)-(+)-norephedrine.
14. A process according to claim 12 wherein said borane reducing agent is borane methylsulfide complex, said reaction inert solvent is tetrahydrofuran, said reaction inert atmosphere is nitrogen, the temperature of the reaction mixture is ambient temperature and the chiral oxazaborolidine catalyst is prepared in situ by reacting said borane methylsulfide complex with (1S, 2R)-(+)-norephedrine.
15. A process according to claim 12 wherein said borane reducing agent is borane methylsulfide complex, said reaction inert solvent is toluene, said reaction inert atmosphere is nitrogen, the temperature of the reaction mixture is ambient temperature and the chiral oxazaborolidine catalyst is prepared in situ by reacting said borane methylsulfide complex with (1S, 2R)-(+)-2-amino-1,2-diphenyl ethanol.
16. A process according to claim 12 wherein said borane reducing agent is borane methylsulfide complex, said reaction inert solvent is tetrahydrofuran, said reaction inert atmosphere is nitrogen, the temperature of the reaction mixture is ambient temperature and the chiral oxazaborolidine catalyst is prepared in situ by reacting said borane methylsulfide complex with (1S, 2R)-(+)-2-amino-1,2-diphenyl ethanol.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9283293A | 1993-07-16 | 1993-07-16 | |
US08/092,832 | 1993-07-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2167287A1 true CA2167287A1 (en) | 1995-01-26 |
Family
ID=22235378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002167287A Abandoned CA2167287A1 (en) | 1993-07-16 | 1994-04-06 | Enantioselective process for thiazole intermediates |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0708764A1 (en) |
JP (1) | JPH08507310A (en) |
CA (1) | CA2167287A1 (en) |
FI (1) | FI960180A0 (en) |
WO (1) | WO1995002585A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0426164D0 (en) | 2004-11-29 | 2004-12-29 | Novartis Ag | Organic compounds |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4943635A (en) * | 1987-08-27 | 1990-07-24 | President & Fellows Of Harvard College | Enantioselective reduction of ketones |
CA2111446C (en) * | 1991-07-22 | 1997-12-16 | George J. Quallich | Chiral intermediates for the preparation of antidiabetics thiazoles |
AU659929B2 (en) * | 1992-05-14 | 1995-06-01 | Pfizer Inc. | Enantioselective oxazaborolidine catalysts |
-
1994
- 1994-04-06 JP JP6520398A patent/JPH08507310A/en active Pending
- 1994-04-06 WO PCT/IB1994/000062 patent/WO1995002585A1/en not_active Application Discontinuation
- 1994-04-06 CA CA002167287A patent/CA2167287A1/en not_active Abandoned
- 1994-04-06 EP EP94910017A patent/EP0708764A1/en not_active Withdrawn
-
1996
- 1996-01-15 FI FI960180A patent/FI960180A0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FI960180A (en) | 1996-01-15 |
EP0708764A1 (en) | 1996-05-01 |
WO1995002585A1 (en) | 1995-01-26 |
JPH08507310A (en) | 1996-08-06 |
FI960180A0 (en) | 1996-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6005133A (en) | Enantioselective oxazaborolidine catalysts | |
US5552548A (en) | Enantioselective oxazaborolidine catalysts | |
Clariana et al. | Nickel (II)-catalyzed Michael additions. Formation of quaternary centers and diastereoselective addition of enantiopure N-acetoacetyl-4-benzyloxazolidin-2-one | |
US5495054A (en) | Tetrahydroindeno[1,2-D][1,3,2]oxazaboroles and their use as enantioselective catalysts | |
AU660701B2 (en) | Process for the preparation of intermediates in the synthesis of chiral thiazolidine-2,4-dione derivatives | |
JP2014040457A (en) | Method of manufacturing phosphoroamide compound and optically active alcohol | |
EP1458729B1 (en) | (aryl) (amino) borane compounds, method for preparing same | |
CA2167287A1 (en) | Enantioselective process for thiazole intermediates | |
US6509472B2 (en) | 4-Cyclohexyl-1,3,2-oxazaborolidine chiral accessories | |
CN111533655B (en) | Preparation method of long-carbon-chain keto dicarboxylic ester | |
US20030153781A1 (en) | Aminothiol compounds and acylated derivatives thereof | |
US5146003A (en) | 3-amino-2-hydroxybornane derivatives, asymmetric michael reaction using the same, and process for preparing optically active muscone utilizing michael reaction | |
KR101446708B1 (en) | Optically active ethylenediamine derivatives and prepartion method thereof | |
Kafka et al. | Hydroboration of 1-(5-hexenyl) piperidine and trans–1-(3-hexenyl) piperidine | |
KR900002052B1 (en) | Process for preparing piperidine derivatives | |
CN116621774A (en) | Synthesis method of allylic aza-aryl methylamine compound | |
JPH03176496A (en) | Ferrocenyl derivative and its utilization | |
NL8204775A (en) | PROCESS FOR THE PREPARATION OF ENCAINIDE. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |